Financial & competing interests disclosure
JC Bell is a founder and sits on the Board of Directors for Turnstone Biologics. JCB is supported by the Canadian Institutes of Health Research (CIHR), the Canadian Cancer Society Research Institute, the Ontario Institute of Cancer Research, and the Terry Fox Foundation. ATC is supported by a CIHR Master’s Award. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.